Literature DB >> 15082339

Nanomedicines for overcoming biological barriers.

Maria José Alonso1.   

Abstract

Drug delivery is an interdisciplinary area of research that aims at making the administration of complex new drugs feasible, as well as adding critical value to the drugs that are currently in the market. At present, one of the most attractive areas of research in drug delivery is the design of nanomedicines consisting of nanosystems that are able to deliver drugs to the right place, at appropriate times. The goal of the present article is to review the advances we have made in the development and characterization of nanosystems intended to be used as drug carriers for mucosal administration. These nanocarriers are able to protect the associated drug against degradation and facilitate its transport across critical and specific barriers. Some of them, are further able to release the associated drug to the target tissue in a controlled manner. These nanocarriers have been made of safe materials, including synthetic biodegradable polymers, lipids and polysaccharides. A number of nanotechnologies have been developed that enable the association of a variety of drugs to these nanocarriers, ranging from classical small drug to large DNA fragments. The in vitro cell culture studies and the in vivo experiments have evidenced the potential of these nanocarriers for overcoming important mucosal barriers, such as the intestinal, nasal and ocular barriers. Hopefully, this will soon represent a strategy for making cheaper and faster, more efficacious medicines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082339     DOI: 10.1016/j.biopha.2004.01.007

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  29 in total

Review 1.  Advances in the use of tocols as drug delivery vehicles.

Authors:  Panayiotis P Constantinides; Jihong Han; Stanley S Davis
Journal:  Pharm Res       Date:  2006-01-25       Impact factor: 4.200

Review 2.  From nutraceuticals to pharmaceuticals to nanopharmaceuticals: a case study in angiogenesis modulation during oxidative stress.

Authors:  Shaker A Mousa; Dhruba J Bharali; Donald Armstrong
Journal:  Mol Biotechnol       Date:  2007-09       Impact factor: 2.695

3.  Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.

Authors:  Hyuncheol Kim; Shaun B Robinson; Karl G Csaky
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

4.  Multifunctional nanomedicines: potentials and prospects.

Authors:  Udita Agrawal; Madhu Gupta; Rajesh S Jadon; Rajeev Sharma; S P Vyas
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

Review 5.  A role for ultrasound in the fabrication of carbohydrate-supported nanomaterials.

Authors:  Smritilekha Bera; Dhananjoy Mondal
Journal:  J Ultrasound       Date:  2019-02-27

6.  Impacts of nanomedicines in ocular pharmacotherapy.

Authors:  Ailar Nakhlband; Jaleh Barar
Journal:  Bioimpacts       Date:  2011-06-09

Review 7.  Physicochemical properties of mucus and their impact on transmucosal drug delivery.

Authors:  Jasmim Leal; Hugh D C Smyth; Debadyuti Ghosh
Journal:  Int J Pharm       Date:  2017-09-14       Impact factor: 5.875

8.  Evaluation of the efficiency of tumor and tissue delivery of carrier-mediated agents (CMA) and small molecule (SM) agents in mice using a novel pharmacokinetic (PK) metric: relative distribution index over time (RDI-OT).

Authors:  Andrew J Madden; Sumit Rawal; Katie Sandison; Ryan Schell; Allison Schorzman; Allison Deal; Lan Feng; Ping Ma; Russell Mumper; Joseph DeSimone; William C Zamboni
Journal:  J Nanopart Res       Date:  2014-11-01       Impact factor: 2.253

9.  Chemopreventive efficacy of naringenin-loaded nanoparticles in 7,12-dimethylbenz(a)anthracene induced experimental oral carcinogenesis.

Authors:  Nechikkad Sulfikkarali; Narendran Krishnakumar; Shanmugam Manoharan; Ramadas Madhavan Nirmal
Journal:  Pathol Oncol Res       Date:  2012-12-12       Impact factor: 3.201

Review 10.  Nanoparticles in modern medicine: state of the art and future challenges.

Authors:  Shashi K Murthy
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.